Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.42 USD | -1.09% | -0.68% | -3.28% |
Mar. 05 | Top Premarket Gainers | MT |
Feb. 09 | Edesa Biotech, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 14.37M |
---|---|---|---|---|---|
Net income 2024 * | -8M | Net income 2025 * | -10M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.92
x | P/E ratio 2025 * |
-2.68
x | Employees | 16 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 71.65% |
1 day | -0.21% | ||
1 week | +0.20% | ||
Current month | +6.37% | ||
1 month | +8.23% | ||
3 months | -3.90% | ||
6 months | +36.57% | ||
Current year | -2.43% |
Managers | Title | Age | Since |
---|---|---|---|
Pardeep Nijhawan
FOU | Founder | 53 | 07-06-11 |
Michael Brooks
PSD | President | 46 | 15-08-31 |
Stephen Lemieux
DFI | Director of Finance/CFO | 48 | 23-07-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sean MacDonald
BRD | Director/Board Member | 47 | 19-06-06 |
Frank Oakes
BRD | Director/Board Member | 73 | 10-04-08 |
Patrick Marshall
BRD | Director/Board Member | 53 | 23-05-22 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 4.42 | -1.09% | 2 293 |
24-04-25 | 4.468 | +3.68% | 2,359 |
24-04-24 | 4.31 | -3.47% | 5,087 |
24-04-23 | 4.465 | +1.94% | 2,343 |
24-04-22 | 4.38 | -1.57% | 812 |
Delayed Quote Nasdaq, April 26, 2024 at 10:12 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.43% | 14.37M | |
-2.08% | 103B | |
+0.52% | 95.71B | |
+1.69% | 22.02B | |
-16.80% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-15.00% | 15.52B | |
+3.65% | 13.86B | |
+33.95% | 12.04B |
- Stock Market
- Equities
- EDSA Stock